Anti-Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development.
about
Anti-Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Anti-Programmed Cell Death 1/L ...... he Art and Future Development.
@en
Anti-Programmed Cell Death 1/Ligand 1
@nl
type
label
Anti-Programmed Cell Death 1/L ...... he Art and Future Development.
@en
Anti-Programmed Cell Death 1/Ligand 1
@nl
prefLabel
Anti-Programmed Cell Death 1/L ...... he Art and Future Development.
@en
Anti-Programmed Cell Death 1/Ligand 1
@nl
P2093
P2860
P1476
Anti-Programmed Cell Death 1/L ...... he Art and Future Development.
@en
P2093
Andrea B Apolo
Andrea Necchi
Galit Rosen
Subramanian Hariharan
Thomas Powles
P2860
P356
10.1016/J.CLGC.2017.11.002
P407
P577
2017-12-06T00:00:00Z